WHY IT MATTERS: If you are a current or prospective cannabis patient, understanding your personal risk factors for dependence helps you and your physician build a safer, more individualized treatment plan with appropriate monitoring. CLINICAL OVERVIEW: Understanding the risk profile for cannabis dependence is a critical clinical question that helps physicians identify which adult patients can use cannabis therapeutically with lower likelihood of developing problematic use patterns. Factors such as age of initiation, mental health history, frequency of use, genetic predisposition, and the presence of other substance use disorders all contribute to a patient’s overall risk profile.
Teen Cannabis Use Tied to Increase in Serious Mental Illness – Medscape
WHY IT MATTERS: If you are a parent or caregiver of a teen, or a young person using cannabis yourself, this research reinforces that delaying use until the brain is more fully developed, typically into the mid-20s, is one of the most important harm reduction strategies available. CLINICAL OVERVIEW: Emerging research continues to reinforce what clinicians have observed for years: adolescent cannabis use, particularly during critical neurodevelopmental windows, is associated with a meaningful increase in risk for serious psychiatric conditions including psychotic and bipolar disorders. The developing brain remains uniquely vulnerable to exogenous cannabinoids, and the endocannabinoid system plays a central role in synaptic pruning and neural circuit maturation during the teenage years.
Cannabis Use by Teenagers Doubles Their Risk of Developing Psychotic and Bipolar Disorders
With cannabis potency at historic highs, this study underscores that adolescent brains are uniquely vulnerable to THC exposure, and parents should understand the psychiatric risks before dismissing cannabis as harmless. Data from a JAMA Health Forum study of nearly half a million teenagers demonstrates that adolescent cannabis use doubles the risk of psychotic and bipolar disorder diagnoses by early adulthood. The association persisted across demographic subgroups and was temporally consistent, with cannabis use preceding psychiatric diagnoses by roughly two years on average.
Kaiser Study Finds Higher Risk of Psychiatric Disorders in Teens Who Use Cannabis
If your teenager uses cannabis, this large-scale study suggests the psychiatric risks are real and significant, particularly for psychosis and bipolar disorder during a critical window of brain development. A Kaiser Permanente-led study published in JAMA Health Forum followed over 463,000 adolescents aged 13 to 17 through age 26 and found that past-year cannabis use was associated with a doubled risk of developing psychotic and bipolar disorders. Cannabis use preceded psychiatric diagnoses by an average of 1.7 to 2.3 years, suggesting a temporal relationship between adolescent exposure and later psychiatric illness.
Takedown of Recent JAMA Cannabis Review
JAMA’s cannabis review is being treated like a verdict. It isn’t. This physician-led analysis explains what the science actually shows—and what it doesn’t—about cannabis risks, benefits, and clinical reality.
Cannabis and Psychosis: 5 Reasons This Study Doesn’t Say What You Think
A new study shows a 5x rise in cannabis-linked psychosis hospitalizations—but is it the plant, or the policy? This blog pulls back the curtain on what’s really behind the numbers: vague diagnoses, missing context, and a health system still catching up. Because when cannabis becomes the scapegoat, we miss the chance to protect the people actually at risk.